Medscape2h
Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Medindia2d
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Healio6d
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
US biochemist researching treatment of HIV and coronaviruses wins Israel’s Wolf Prize
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Tech Explorist5d
Breakthrough antibody therapies offer hope for HIV treatment
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
India Today on MSN1h
IIT Roorkee researchers discover potential drug to treat Chikungunya
Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...
Fierce Biotech6d
Immunocore T-cell engager clears safety hurdle, reduces HIV reservoir in some patients
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
PharmExec2d
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Montgomery Advertiser on MSN2d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Morningstar6d
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Such ‘regained’ post-treatment control may be associated with an immune response to the virus. There was also a reduction in CD4+ T cell-associated HIV Gag RNA in some PLWH during treatment ...